Results of a randomised, placebo-controlled six-month study of memantine in the treatment of mild to moderate Alzheimer's disease in Europe

被引：0

作者：

Bakchine, S.

Pascual-Gangnant, L.

Loft, H.

机构：

[1] Hop Blanche, Reims, France

[2] Lundbeck SA, Paris, France

[3] H Lundbeck & Co AS, Valby, Denmark

来源：

EUROPEAN JOURNAL OF NEUROLOGY | 2005年 / 12卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：187 / 187

页数：1

共 50 条

[1] Results of a randomised, placebo-controlled 6-month study of memantine in the treatment of mild to moderate Alzheimer's disease in Europe
Bakchine, S
Pascual-Gangnant, L
Hefting, N
Loft, H
[J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S567 - S568
[2] Memantine treatment in patients with mild to moderate Alzheimer's disease: Results of a randomised, double-blind, placebo-controlled 6-month study
Bakchine, S.
Loft, H.
[J]. JOURNAL OF ALZHEIMERS DISEASE, 2008, 13 (01) : 97 - 107
[3] Memantine treatment in patients with mild to moderate Alzheimer's disease: Results of a randomised, double-blind, placebo-controlled 6-month study
Bakchine, S.
Loft, H.
[J]. JOURNAL OF ALZHEIMERS DISEASE, 2007, 11 (04) : 471 - 479
[4] Meta-analysis of six-month memantine trials in Alzheimer's disease. Memantine has negligible benefits in mild to moderate Alzheimer's disease
Knopman, David S.
[J]. ALZHEIMERS & DEMENTIA, 2007, 3 (01) : 21 - 22
[5] Safety and efficacy of piribedil as adjunctive treatment for Parkinson's disease: Six-month placebo-controlled study
Fedorova, N
Jamrozik, Z
Takacs, A
Ruzicka, E
Del Signore, S
Kwiecinski, H
[J]. MOVEMENT DISORDERS, 2002, 17 : S101 - S102
[6] A placebo-controlled study of memantine in advanced Alzheimer's disease.
Reisberg, B
Stoeffler, A
Ferris, S
Schmitt, F
Doody, R
Moebuis, HJ
[J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2002, 10 (02): : 90 - 90
[7] Memantine treatment of cognitive symptoms in mild to moderate Alzheimer disease: Secondary analyses from a placebo-controlled randomized trial
Pomara, Nunzio
Ott, Brian R.
Peskind, Elaine
Resnick, E. Malca
[J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2007, 21 (01): : 60 - 64
[8] Meta-analysis of six-month memantine trials in Alzheimer's disease
Doody, Rachelle Smith
Tariot, Pierre N.
Pfeiffer, Eric
Olin, Jason T.
Graham, Stephen M.
[J]. ALZHEIMERS & DEMENTIA, 2007, 3 (01) : 7 - 17
[9] Memantine in the treatment of mild-to-moderate Alzheimer's disease
Cosman, Kelly M.
Boyle, Llsa L.
Porsteinsson, Anton P.
[J]. EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (02) : 203 - 214
[10] MEMANTINE IN THE TREATMENT OF MILD TO MODERATE DEMENTIA SYNDROME - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
GORTELMEYER, R
ERBLER, H
[J]. ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1992, 42-2 (07): : 904 - 913

← 1 2 3 4 5 →